Our ESG team has a robust understanding of the regulatory and policy drivers of the market and experience across a wide range of sectors and contexts.
Linklaters Appoints Carl Fernandes as Global Head of Financial Regulation Group
7 April 2025
Linklaters is pleased to announce the appointment of Hong Kong Financial Regulation Group partner Carl Fernandes as the new Global Head of Financial Regulation Group. Carl succeeds Peter Bevan who successfully led the practice group over the past ten years and will be assuming the title of Global Chair of Financial Regulation.
Linklaters advises Ontex on its successful high-yield issuance and concurrent cash tender offer
4 April 2025
Linklaters has advised Ontex, a leading international developer and producer of personal care products for retailers and healthcare providers, on the successful offering of €400 million high yield bond.
Linklaters advises Intel on the sale of its NAND flash memory and SSD business to SK hynix
2 April 2025
Linklaters advised Intel on the completion of the second phase of the sale of its NAND flash memory and SSD business to SK hynix, marking the official completion of the entire transaction.
Wolfram Krüger appointed Global Head of Real Estate
21 March 2025
Linklaters is pleased to announce the appointment of Frankfurt real estate partner Wolfram Krüger as the new Global Head of Real Estate. He succeeds Andy Bruce from the London office, who successfully led the practice group for two four-year terms since 2017.
Linklaters advises Novo Holdings on the merger control and foreign investments aspects of its investment in Biocomposites alongside TA Associates
17 March 2025
Linklaters advises Novo Holdings on the merger control and foreign investments aspects of its investment in Biocomposites alongside TA Associates Linklaters has secured various unconditional merger control and foreign investment clearances for Novo Holdings, a holding and investment company that is responsible for managing the assets and wealth of the Novo Nordisk Foundation, in relation to its investment in Biocomposites, an international medical devices company that engineers, manufactures and markets leading products for use in infection management in bone and soft tissue.
Linklaters is advising General Motors in its partnership with TWG Motorsports to form the Cadillac Formula 1 Team
13 March 2025
Linklaters’ New York M&A team is advising General Motors in its partnership with TWG Motorsports to form the Cadillac Formula 1 Team. The team will join the FIA Formula One World Championship grid in March 2026.